[(89)Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial.
- DOI
- 10.1016/s1470-2045(24)00402-9
- Published
- 2024 Oct
- Container
- The Lancet. Oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1470-2045-24-00402-9,
title = {[(89)Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial.},
author = {Shuch B and Pantuck AJ and Bernhard JC and Morris MA and Master V and Scott AM and van Praet C and Bailly C and Önal B and Aksoy T and Merkx R and Schuster DM and Lee ST and Pandit-Taskar N and Fan AC and Allman P and Schmidt K and Tauchmanova L and Wheatcroft M and Behrenbruch C and Hayward CRW and Mulders P},
year = {2024},
journal = {The Lancet. Oncology},
doi = {10.1016/s1470-2045(24)00402-9},
url = {https://doi.org/10.1016/s1470-2045(24)00402-9}
}RIS
TY - JOUR TI - [(89)Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial. AU - Shuch B AU - Pantuck AJ AU - Bernhard JC AU - Morris MA AU - Master V AU - Scott AM AU - van Praet C AU - Bailly C AU - Önal B AU - Aksoy T AU - Merkx R AU - Schuster DM AU - Lee ST AU - Pandit-Taskar N AU - Fan AC AU - Allman P AU - Schmidt K AU - Tauchmanova L AU - Wheatcroft M AU - Behrenbruch C AU - Hayward CRW AU - Mulders P PY - 2024 JO - The Lancet. Oncology DO - 10.1016/s1470-2045(24)00402-9 UR - https://doi.org/10.1016/s1470-2045(24)00402-9 ER -
APA
B, S., AJ, P., JC, B., MA, M., V, M., AM, S., C, V. P., C, B., B, Ö., T, A., R, M., DM, S., ST, L., N, P., AC, F., P, A., K, S., L, T., M, W., C, B., CRW, H., & P, M. (2024). [(89)Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(24)00402-9
Source records
- pubmed · retrieved 2026-09-27T01:33:32.282Z